2024-04-01 2025-03-31 false Capium Accounts Production 1.1 12541634 2024-04-01 2025-03-31 12541634 bus:FullAccounts 2024-04-01 2025-03-31 12541634 bus:FRS102 2024-04-01 2025-03-31 12541634 bus:AuditExemptWithAccountantsReport 2024-04-01 2025-03-31 12541634 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 12541634 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 12541634 2024-04-01 2025-03-31 12541634 2025-03-31 12541634 bus:RegisteredOffice 2024-04-01 2025-03-31 12541634 core:WithinOneYear 2025-03-31 12541634 core:AfterOneYear 2025-03-31 12541634 1 2024-04-01 2025-03-31 12541634 bus:Director1 2024-04-01 2025-03-31 12541634 bus:Director1 2025-03-31 12541634 bus:Director1 2023-04-01 2024-03-31 12541634 bus:Director2 2024-04-01 2025-03-31 12541634 bus:Director2 2025-03-31 12541634 bus:Director2 2023-04-01 2024-03-31 12541634 2023-04-01 12541634 bus:LeadAgentIfApplicable 2024-04-01 2025-03-31 12541634 2023-04-01 2024-03-31 12541634 2024-03-31 12541634 core:WithinOneYear 2024-03-31 12541634 core:AfterOneYear 2024-03-31 12541634 bus:EntityAccountantsOrAuditors 2023-04-01 2024-03-31 12541634 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 12541634 bus:OrdinaryShareClass1 2025-03-31 12541634 bus:OrdinaryShareClass1 2023-04-01 2024-03-31 12541634 bus:OrdinaryShareClass1 2024-03-31 12541634 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 12541634 bus:OrdinaryShareClass2 2025-03-31 12541634 bus:OrdinaryShareClass2 2023-04-01 2024-03-31 12541634 bus:OrdinaryShareClass2 2024-03-31 12541634 core:CostValuation core:Non-currentFinancialInstruments 2025-03-31 12541634 core:CostValuation core:Non-currentFinancialInstruments 2024-03-31 12541634 core:AdditionsToInvestments core:Non-currentFinancialInstruments 2025-03-31 12541634 core:DisposalsDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 12541634 core:RevaluationsIncreaseDecreaseInInvestments core:Non-currentFinancialInstruments 2025-03-31 12541634 core:Non-currentFinancialInstruments 2025-03-31 12541634 core:Non-currentFinancialInstruments 2024-03-31 12541634 core:ShareCapital 2025-03-31 12541634 core:ShareCapital 2024-03-31 12541634 core:RetainedEarningsAccumulatedLosses 2025-03-31 12541634 core:RetainedEarningsAccumulatedLosses 2024-03-31 12541634 dpl:Item1 2024-04-01 12541634 dpl:Item1 2025-03-31 12541634 dpl:Item1 2023-04-01 12541634 dpl:Item1 2024-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered Number: 12541634
England and Wales

 

 

 


Unaudited Financial Statements


for the year ended 31 March 2025

for

KENKID LTD.

 
 
Notes
 
2025
£
  2024
£
Current assets      
Debtors 3   697 
Cash at bank and in hand 42,920    33,229 
42,920    33,926 
Creditors: amount falling due within one year 4 (28,443)   (16,708)
Net current assets 14,477    17,218 
 
Total assets less current liabilities 14,477    17,218 
Net assets 14,477    17,218 
 

Capital and reserves
     
Called up share capital 5 100    100 
Profit and loss account 14,377    17,118 
Shareholders' funds 14,477    17,218 
 


For the year ended 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:
  1. The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
  2. The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.
The financial statements were approved by the board of directors on 12 August 2025 and were signed on its behalf by:


-------------------------------
D Kidney
Director
1
General Information
Kenkid LTD. is a private company, limited by shares, registered in England and Wales, registration number 12541634, registration address 207 Tenby House, 12 Tenby Street South, Birmingham, West Midlands , B1 3QB.

The presentation currency is £ sterling.
1.

Accounting policies

Significant accounting policies
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, the Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by Section 1A of the standard)
Turnover
Turnover comprises the invoiced value of goods and services supplied by the company, net of Value Added Tax and trade discounts.
Taxation
Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted
Debtors and creditors receivable/ payable within one year
Debtors and creditors with no stated interest rate and receivable or payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in the other administrative expenses.
Cash and cash equivalents
Cash at bank and in hand are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
2.

Average number of employees

Average number of employees during the year was 2 (2024 : 2).
3.

Debtors: amounts falling due within one year

2025
£
  2024
£
Other Debtors   697 
  697 

4.

Creditors: amount falling due within one year

2025
£
  2024
£
Taxation and Social Security 15,779    12,001 
Other Creditors 12,664    4,707 
28,443    16,708 

5.

Share Capital

Allotted, called up and fully paid
2025
£
  2024
£
25 Class A shares of £1.00 each 25    25 
75 Class B shares of £1.00 each 75    75 
100    100 

2